Document Detail


Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
MedLine Citation:
PMID:  23165463     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
M Shoai Tehrani; F Sicre de Fontbrune; P Roth; C Allisy; M-E Bougnoux; O Hermine; M Lecuit; O Lortholary; C Charlier
Related Documents :
22689723 - The use of fetal fibronectin testing in the management of a triplet pregnancy with a sh...
23116253 - Pregnancy outcomes and factors associated with voluntary pregnancy termination in women...
11339183 - Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: ...
Publication Detail:
Type:  Case Reports; Letter     Date:  2012-11-19
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  57     ISSN:  1098-6596     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-23     Completed Date:  2013-07-29     Revised Date:  2013-08-12    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1094-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aspergillosis / drug therapy*
Aspergillus flavus / drug effects,  isolation & purification
Female
Humans
Pregnancy
Pregnancy Trimester, Third
Pyrimidines / adverse effects*,  pharmacology,  therapeutic use*
Triazoles / adverse effects*,  pharmacology,  therapeutic use*
Chemical
Reg. No./Substance:
0/Pyrimidines; 0/Triazoles; 0/voriconazole
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing sche...
Next Document:  Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis.